![]() | |
![]() | |
Clinical data | |
---|---|
Routes of administration | oral, intranasal, rectal |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.077 ![]() |
Chemical and physical data | |
Formula | C15H23N |
Molar mass | 217.356 g·mol−1 |
3D model (JSmol) | |
Melting point | 133 °C (271 °F) |
Boiling point | 153 °C (307 °F) |
| |
| |
![]() ![]() |
Prolintane (Catovit, Katovit, Promotil, Villescon) is a stimulant[2] and norepinephrine-dopamine reuptake inhibitor developed in the 1950s.[3] Being an amphetamine derivative, it is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action.[4] Many cases of prolintane abuse have been reported.[5]
Under the trade-name "Katovit", prolintane was commercialized by the Spanish pharmaceutical company, FHER. Katovit was sold until 2001, and was most often used by students and workers as a stimulant to provide energy, promote alertness and concentration.[medical citation needed]
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |